FRANZINI, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 7.535
EU - Europa 5.967
AS - Asia 4.559
SA - Sud America 1.057
AF - Africa 115
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 10
Totale 19.260
Nazione #
US - Stati Uniti d'America 7.152
SG - Singapore 1.682
GB - Regno Unito 1.493
RU - Federazione Russa 1.242
CN - Cina 1.213
IT - Italia 1.048
BR - Brasile 846
VN - Vietnam 785
UA - Ucraina 491
PL - Polonia 360
DE - Germania 357
HK - Hong Kong 328
CA - Canada 276
FI - Finlandia 253
FR - Francia 186
DK - Danimarca 153
SE - Svezia 112
IE - Irlanda 90
IN - India 89
MX - Messico 81
AR - Argentina 79
NL - Olanda 60
BD - Bangladesh 57
ID - Indonesia 53
TR - Turchia 49
IQ - Iraq 45
KR - Corea 45
JP - Giappone 43
ZA - Sudafrica 40
EC - Ecuador 36
IL - Israele 33
ES - Italia 27
PK - Pakistan 23
CL - Cile 22
VE - Venezuela 19
AT - Austria 18
CO - Colombia 17
MA - Marocco 17
EU - Europa 16
LT - Lituania 16
UZ - Uzbekistan 15
PY - Paraguay 14
RO - Romania 13
SA - Arabia Saudita 13
MY - Malesia 12
CH - Svizzera 11
EG - Egitto 11
PE - Perù 11
AE - Emirati Arabi Uniti 10
KE - Kenya 10
SK - Slovacchia (Repubblica Slovacca) 10
TW - Taiwan 10
DZ - Algeria 8
NP - Nepal 8
TN - Tunisia 8
BO - Bolivia 7
PH - Filippine 7
AZ - Azerbaigian 6
CR - Costa Rica 6
JO - Giordania 6
AU - Australia 5
BE - Belgio 5
SN - Senegal 5
KZ - Kazakistan 4
MM - Myanmar 4
NI - Nicaragua 4
UY - Uruguay 4
AL - Albania 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
IR - Iran 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
OM - Oman 3
AM - Armenia 2
GD - Grenada 2
GR - Grecia 2
HN - Honduras 2
LV - Lettonia 2
NG - Nigeria 2
PA - Panama 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
SR - Suriname 2
TT - Trinidad e Tobago 2
AO - Angola 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BT - Bhutan 1
CG - Congo 1
CU - Cuba 1
CZ - Repubblica Ceca 1
DM - Dominica 1
EE - Estonia 1
Totale 19.242
Città #
Dallas 1.345
Southend 1.186
Singapore 881
Beijing 528
San Jose 507
Ashburn 497
Chandler 412
Warsaw 354
Hong Kong 307
San Mateo 287
Pisa 243
Fairfield 240
Woodbridge 235
Jacksonville 227
Ann Arbor 208
Moscow 208
Houston 192
Ho Chi Minh City 182
Helsinki 165
Cambridge 162
Wilmington 160
The Dalles 148
Seattle 143
Dong Ket 140
Hanoi 132
Dearborn 129
Los Angeles 128
Falls Church 126
Council Bluffs 121
Boardman 114
New York 100
Hefei 92
Stevenage 92
Beauharnois 86
Dublin 84
São Paulo 82
Portsmouth 81
Lauterbourg 78
Milan 76
Ottawa 76
Lawrence 74
Santa Clara 58
Buffalo 50
Brooklyn 44
Rome 42
Montréal 40
Munich 39
Tokyo 38
Montreal 35
Da Nang 34
Mexico City 32
Seoul 32
Chicago 31
London 31
Orem 31
Johannesburg 29
Rio de Janeiro 28
Tel Aviv 28
Amsterdam 24
Bologna 24
San Diego 24
Denver 23
Haiphong 22
Brasília 21
Chennai 20
Redwood City 20
San Francisco 20
Stockholm 20
Boston 19
Baghdad 18
Florence 18
Frankfurt am Main 18
Kansas City 18
Poplar 16
Atlanta 15
Nuremberg 15
Toronto 15
Turin 15
Biên Hòa 14
Manchester 14
Old Bridge 14
Phoenix 14
Tashkent 14
Ankara 13
Jakarta 13
Potenza 13
Quito 13
Norwalk 12
Pavia 12
Porto Alegre 12
Querétaro 12
Redondo Beach 12
Santiago 12
Shenzhen 12
Belo Horizonte 11
Campinas 11
Dhaka 11
Istanbul 11
Lucca 11
Molfetta 11
Totale 11.907
Nome #
A High Performance Gel Filtration Chromatography Method for gamma-Glutamyltransferase Fraction Analysis 406
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 395
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 382
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 365
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 334
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 330
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 326
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases. 319
Gamma-glutammiltransferasi (GGT): biochimica clinica e patologia umana (Rassegna) 316
Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: some results. 316
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 312
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 302
Biomarcatori di stabilità della placca aterosclerotica (Rassegna) 292
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 292
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 283
Evaluation of analytical performance of a novel immunoenzymometric assay for cTnI. 281
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 277
Cardiac biomarker testing in the clinical laboratory:Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. 273
Antioxidant capacity and protein oxidation in cerebrospinal fluid of amyotrophic lateral sclerosis. 266
Marcatori di rimodellamento e fibrosi cardiaca 264
A kinetic study of gamma-glutamyltransferase (GGT)-mediated S-nitrosoglutathione catabolism. 263
Circulating gamma-glutamyltransferase fractions in cirrhosis. 256
Indici di laboratorio di stress ossidativo. 255
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 252
Are standard cell culture conditions adequate for human umbilical cord blood mesenchymal stem cells? 245
A novel marker of progression for atherosclerosis and cardiovascular diseases: serum gamma-glutamyltransferase enzyme activity. 243
Stato dell’arte dell’immunodosaggio dei peptidi natriuretici di tipo B 242
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 242
RNA-targeting and gene editing therapies for transthyretin amyloidosis 238
Rilevanza clinica e interpretazione dei marcatori biochimici nello scompenso cardiaco 237
Criteri per la valutazione delle caratteristiche analitiche e della utilità clinica dei nuovi biomarcatori cardiaci 235
State of the art of aldosterone immunoassays. A multicenter collaborative study on the behalf of the Cardiovascular Biomarkers Study Group of the Italian Section of European Society of Ligand Assay (ELAS) and Società Italiana di Biochimica Clinica (SIBIOC). 234
Aortic valve disease and gamma-glutamyltransferase: accumulation in tissue and relationships with calcific degeneration. 234
Big gamma-glutamyltransferase is associated with epicardial fat volume and cardiovascular outcome in the general population 231
gamma-Glutamyltransferase activity in human atherosclerotic plaques – biochemical similarities with the circulating enzyme. 222
Myocardial Infarction Following COVID-19 Vaccine Administration: Post Hoc, Ergo Propter Hoc? 221
State of the Art of Immunoassay Methods for B-Type Natriuretic Peptides: an Update 208
Reference values for alanine aminotransferase, α-amylase, aspartate aminotransferase, γ-glutamyltransferase and lactate dehydrogenase measured according to the IFCC standardization during uncomplicated pregnancy. 208
Systematic differences between BNP immunoassays: comparison of methods using standard protocols and quality control materials 206
State of the art of aldosterone immunoassays. 204
Forme molecolari della gamma-glutammiltransferasi: caratteristiche e biogenesis. 203
Correlates and reference limits of plasma gamma-glutamyltransferase fractions from the Framingham Heart Study. 203
Valutazione di un metodo di dosaggio del BNP nel sangue capillare 202
Fractions of plasma gamma-glutamyltransferase in healthy individuals: Reference values. 198
State of the art of BNP and NT-proBNP immunoassays: The CardioOrmoCheck study. 198
The potential roles of gamma-glutamyltransferase activity in the progression of atherosclerosis and cardiovascular diseases. 196
Serum gamma-glutamyltransferase: linking together environmental pollution, redox equilibria and progression of atherosclerosis? 196
Valutazione delle prestazioni analitiche del nuovo metodo per il dosaggio dell’aldosterone che utilizza la piattaforma LIAISON: confronto con altri metodi immunometrcici e con la psettrometria di massa 195
Contribution by polymorphonucleate granulocytes to elevated gamma-glutamyltransferase in cystic fibrosis sputum. 187
Serum gamma-glutamyltransferase and intima-media thickness: pointing again to wall/lumen interactions in atherosclerosis. 184
Antithrombotic properties of Tafamidis: An additional protective effect for transthyretin amyloid cardiomyopathy patients 183
Biomarkers for growth prediction of abdominal aortic aneurysm: A step forward(?) 183
Forme molecolari dela gamma-glutammiltransferasi: caratteristiche e biogenesi 182
Gamma-glutamyltransferase fractions in human plasma and bile: Characteristic and biogenesis 182
Gamma-glutamyltransferase, H(2)O(2)-induced apoptosis and expression of catalase. 180
Stato dell’arte del dosaggio dei peptidi BNP e NT-proBNP: il controllo di qualità esterno CardioOrmoCheck 180
gamma-glutamiltransferasi e stress ossidativo. 178
Method of detecting and separating serum gamma-glutamyltransferase (GGT) isoforms in a sample of biological fluid and the enzyme isoforms thereby obtained 178
PROCESS FOR DETERMINING S-NITROSOTHIOLS IN BIOLOGICALFLUIDS 174
Big and Free Fractions of Gamma-Glutamyltransferase: New Diagnostic Biomarkers for Malignant Mesothelioma? 173
The S-thiolating activity of membrane gamma-glutamyltransferase: formation of cysteinyl-glycine mixed disulfides with cellular proteins and in the cell microenvironment. 173
Pathophysiology of Cardiac Amyloidosis 172
Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy 172
Developmental variations of plasma gamma-glutamyltransferase fractions in humans and in laboratory mammalians. 172
Helicobacter, gamma-glutamyltransferase and cancer: further intriguing connections 172
Gamma-glutamyltransferase of cancer cells at the crossroads of tumor progression, drug resistance and drug targeting 170
Vitamin C supply to bronchial epithelial cells linked to glutathione availability in elf - A role for secreted gamma-glutamyltransferase. 169
Cystic fibrosis, elevated gamma-glutamyltransferase, and lung transplant outcome. 169
Serum gamma-glutamyltransferase fractions in Myotonic Dystrophy type I: Differences with healthy subjects and patients with liver disease. 165
γ-Glutamyltransferase Fractions in Obese Subjects with Type 2 Diabetes: Relation to Insulin Sensitivity and Effects of Bariatric Surgery 164
Mechanisms and targets of the modulatory action of S-nitrosoglutathione (GSNO) on inflammatory cytokines expression. 163
High-sensitivity gamma-glutamyltransferase fraction pattern in alcohol addicts and abstainers. 161
Cultured human cells release soluble gamma-glutamyltransferase complexes corresponding to the plasma b-GGT 159
Exogenous vs. endogenous gamma-glutamyltransferase activity: Implications for the specific determination of S-nitrosoglutathione in biological samples. 159
The IL-33/ST2 pathway, inflammation and atherosclerosis: Trigger and target? 158
Plasma membrane gamma-glutamyltransferase activity facilitates the uptake of vitamin C in melanoma cells. 157
Use of biomarkers to diagnose and manage cardiac amyloidosis 155
Highly Elevated Plasma γ-Glutamyltransferase Elevations: A Trait Caused by γ-Glutamyltransferase 1 Transmembrane Mutations 154
Gamma-glutamyltransferase independently predicts mortality and hospitalization for heart failure in cardiac transthyretin amyloidosis 151
Gamma-glutamyltransferases: exploring the complexity of a multifunctional family of enzymes 151
gamma-Glutamyl transpeptidase catalyses the extracellular detoxification of cisplatin in a human cell line derived from the proximal convoluted tubule of the kidney. 150
Plasma gamma-glutamyltransferase (GGT) activity in inflammatory bowel disease: is the clinical laboratory plasma GGT assay sensitive enough for gastroenterology? 149
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 148
Modulation of cell growth and cisplatin sensitivity by membrane gamma-glutamyltransferase in melanoma cells. 148
Tetrameric Transthyretin as a Protective Factor Against Alzheimer’s Disease 138
Preliminary study to evaluate the meaning of GGT fractions analysis in a population of workers previously exposed to asbestos 124
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 122
The Journey of Human Transthyretin: Synthesis, Structure Stability, and Catabolism 122
Serum Transthyretin Before and After Starting Tafamidis as Outcome Predictors in ATTR Cardiomyopathy 52
Serum and Tissue Light-Chains as Disease Biomarkers in AL Amyloidosis 51
Biological variability of transthyretin in patients with transthyretin cardiac amyloidosis: implications for therapy monitoring 43
Current Standards and Perspectives in Proteomics for Cardiac Amyloidosis 38
Profiling plasma transthyretin in healthy subjects and patients with cardiac ATTR amyloidosis by native electrophoresis 18
Totale 19.331
Categoria #
all - tutte 88.868
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.868


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021572 0 0 0 0 0 0 0 0 0 101 147 324
2021/20221.122 88 222 40 77 27 28 128 219 66 132 18 77
2022/2023965 80 31 26 163 142 177 19 74 178 15 41 19
2023/2024543 50 24 76 27 17 74 47 44 19 21 48 96
2024/20253.229 46 36 148 77 121 199 506 964 234 143 513 242
2025/20268.206 412 1.523 1.006 1.172 833 580 1.114 398 629 539 0 0
Totale 19.331